The US's #2 ridesharing app has finally shared its financials. Lyft filed publicly for an IPO that we estimate could raise $3 billion. The "decacorn"...read more
Kaleido Biosciences, an early-stage biotech developing oral microbiome therapies, raised $75 million by offering 5 million shares at $15, below the range of $20 to $22. The company had originally planned to raise $100 million by offering 4.8 million shares....read more
Two IPOs and a SPAC plan to raise a combined $350 million in the week ahead. Several companies may launch March IPOs, including cardiovascular disease device maker ShockWave Medical (SWAV), Diamondback midstream services unit...read more
Kaleido Biosciences, an early-stage biotech developing microbiome therapies for rare genetic disorders, announced terms for its IPO on Tuesday. The Lexington, MA-based company plans to raise $100 million by offering 4.8 million shares at a price range of...read more
US IPO Weekly Recap: The IPO market gets a Lyft
The US's #2 ridesharing app has finally shared its financials. Lyft filed publicly for an IPO that we estimate could raise $3 billion. The "decacorn"...read more
The new Five Below: Kaleido Biosciences, a microbiome biotech, prices IPO at $15, $5 below the range
Kaleido Biosciences, an early-stage biotech developing oral microbiome therapies, raised $75 million by offering 5 million shares at $15, below the range of $20 to $22. The company had originally planned to raise $100 million by offering 4.8 million shares....read more
US IPO Week Ahead: A biotech, a SPAC, and e-sports to go public
Two IPOs and a SPAC plan to raise a combined $350 million in the week ahead. Several companies may launch March IPOs, including cardiovascular disease device maker ShockWave Medical (SWAV), Diamondback midstream services unit...read more
Rare genetic disorder biotech Kaleido Biosciences sets terms for $100 million IPO
Kaleido Biosciences, an early-stage biotech developing microbiome therapies for rare genetic disorders, announced terms for its IPO on Tuesday. The Lexington, MA-based company plans to raise $100 million by offering 4.8 million shares at a price range of...read more